Shock Treatment For Teeth Grinding Becoming Acceptable

by Gopalan on  November 15, 2009 at 11:36 AM General Health News   - G J E 4
Shock Treatment For Teeth Grinding Becoming Acceptable
An innovative shock treatment for bruxism is gaining increasing acceptance in Europe. Medtech's Grindcare, launched early this year, is now being trialled in the UK.

Bruxism can cause jaw pain, tense muscles and headaches along with excessive wear on the teeth. More than 20 million people in Europe and the US are estimated to suffer from bruxism. Up to now the only recognised treatment for the condition has been an occlusal splint, also called a bite splint, a type of mouth guard that reduces the frictional damage on the teeth.

Medotech's new product Grindcare is a different device altogether, consisting of a headband with built-in electrodes, a microprocessor and a display. Grindcare is designed to detect the movement pattern in the jaw that leads to bruxism. When the movement is detected, Grindcare sends out a low-grade electrical pulse to relax the muscle and stop it from tensing. According to Medotech's website, repeated use of Grindcare can "teach" the muscle to relax on its own, thereby reducing the need for the device over time.

Treatment with Grindcare does not affect the sleep pattern of patients suffering from Bruxism. Patients and professionals can track the effect of treatment on a daily basis. Patients can rent the device from dentist at a nominal fee before making the decision to buy one for themselves.

Clinical studies have documented that Grindcare can reduce bruxism by more than 50 percent within 3 weeks and up to 80 percent after 6-8 weeks.

Medotech continues to sponsor clinical studies around the world in order to provide further evidence of the efficacy and safety of the new device. Currently clinical studies are in progress at the Danish Head Ache Center at Glostrup Hospital in Copenhagen represented by Professor Rigmor Jensen and at the Dental School at the University of Aarhus, Denmark represented by Professor Peter Svensson. The studies focus on tension type headache and temporomandibular disorders (TMD) characterized by pain and tension in facial muscles and joints.

Medotech launched Grindcare 3.0 at the world's biggest dental fair, IDS, in Cologne from 24 -28 March this year and started distribution in more than 9 European countries. Medotech expects to launch it in the US in 2010.

Source: Medindia

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
Notify me when reply is posted I agree to the terms and conditions

You May Also Like